Table 2.
Prevalence of Intracranial Diseases Detected by Brain Magnetic Resonance Imaging According to Neurological Symptoms
| Intracranial diseases | Patients without neurological symptoms (n=158) | Patients without neurological symptoms with CD4 <200/μl (n=144) | Patients with neurological symptoms (n=327) | Patients with neurological symptoms with CD4 <200/μl (n=113) | Positive toxoplasma Ab and without neurological symptoms (n=38) |
|---|---|---|---|---|---|
| Toxoplasmosis | 2 (1) | 2 (2) | 10 (3) | 10 (7) | 2 (1) |
| PML | 1 (1) | 1 (1) | 7 (2) | 7 (5) | 1 (1) |
| HIV-associated dementia | 17 (6) | 13 (9) | |||
| Malignant lymphoma | 4 (1) | 3 (2) | |||
| CMV encephalopathy | 3 (1) | 3 (2) | |||
| Cryptococcoma/meningitis | 3 (1) | 3 (1) | |||
| HSV encephalopathy | 1 | 1 | |||
| Gummatous syphilis | 1 | 1 | |||
| Tuberculoma | 1 | 1 | |||
| Metastatic cancer | 1 | ||||
| Cerebral infarction | 8 (3) | 2 (1) | |||
| Others | 3 (1) | 2 (1) | |||
| Total | 3 (2) | 3 (3) | 59 (19) | 46 (32) | 3 (8) |
Data are numbers (percentages) of patients.
Ab, antibody; PML, progressive multifocal leukoencephalopathy; CMV, cytomegalovirus; HSV, herpes simplex virus.